Greenleaf Trust Vertex Pharmaceuticals Inc Transaction History

Greenleaf Trust

$10.7 Billion
Q1 2024

A detailed history of Greenleaf Trust transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Greenleaf Trust holds 4,970 shares of VRTX stock, worth $2.35 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

4,970

Previous 4,977 0.14%

Holding current value

$2.35 Million

Previous $2.03 Million 2.57%

% of portfolio

0.02%

Previous 0.02%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	SELL	$407.69 - $446.08 $2,853 - $3,122	-7 Reduced 0.14%	4,970 $2.08 Million
Q4 2023 Jan 31, 2024	BUY	$343.0 - $410.68 $22,981 - $27,515	67 Added 1.36%	4,977 $2.03 Million
Q3 2023 Nov 09, 2023	BUY	$338.18 - $362.46 $56,137 - $60,168	166 Added 3.5%	4,910 $1.71 Million
Q2 2023 Aug 09, 2023	SELL	$314.42 - $351.91 $80,177 - $89,737	-255 Reduced 5.1%	4,744 $1.67 Million
Q1 2023 May 11, 2023	BUY	$283.23 - $323.1 $1,982 - $2,261	7 Added 0.14%	4,999 $1.58 Million

Q4 2022 Jan 25, 2023	BUY	$285.76 - $321.48 $103,445 - $116,375	362 Added 7.82%	4,992 $1.44 Million
Q3 2022 Nov 10, 2022	SELL	$273.83 - $305.53 $8,214 - $9,165	-30 Reduced 0.64%	4,630 $1.34 Million
Q2 2022 Aug 12, 2022	BUY	$234.96 - $292.55 $69,548 - $86,594	296 Added 6.78%	4,660 $1.31 Million
Q1 2022 Apr 27, 2022	BUY	$221.42 - $260.97 $147,687 - $174,066	667 Added 18.04%	4,364 $1.14 Million
Q4 2021 Feb 11, 2022	BUY	$177.01 - $223.45 $284,455 - $359,084	1,607 Added 76.89%	3,697 $812,000
Q3 2021 Nov 12, 2021	SELL	$181.39 - $202.99 $192,454 - $215,372	-1,061 Reduced 33.67%	2,090 $379,000
Q2 2021 Aug 10, 2021	SELL	$187.49 - $221.1 $59,246 - $69,867	-316 Reduced 9.11%	3,151 $635,000
Q1 2021 Apr 30, 2021	BUY	$207.02 - $241.31 $73,492 - $85,665	355 Added 11.41%	3,467 $745,000
Q4 2020 Feb 08, 2021	BUY	$207.01 - $276.09 $44,300 - $59,083	214 Added 7.38%	3,112 $735,000
Q3 2020 Oct 30, 2020	SELL	$255.65 - $303.1 $29,399 - $34,856	-115 Reduced 3.82%	2,898 $789,000
Q2 2020 Aug 12, 2020	BUY	$225.48 - $295.8 $87,486 - $114,770	388 Added 14.78%	3,013 $875,000
Q1 2020 Apr 29, 2020	BUY	$199.77 - $247.81 $61,129 - $75,829	306 Added 13.2%	2,625 $625,000
Q3 2019 Nov 08, 2019	BUY	$166.23 - $187.09 $36,238 - $40,785	218 Added 10.38%	2,319 $393,000
Q2 2019 Jul 24, 2019	SELL	$164.61 - $190.37 $6,913 - $7,995	-42 Reduced 1.96%	2,101 $385,000
Q1 2019 May 08, 2019	BUY	$163.73 - $194.7 $54,849 - $65,224	335 Added 18.53%	2,143 $394,000
Q4 2018 Feb 07, 2019	BUY	$151.91 - $192.21 $21,267 - $26,909	140 Added 8.39%	1,808 $300,000
Q3 2018 Oct 29, 2018	BUY	$167.73 - $192.74 $36,229 - $41,631	216 Added 14.88%	1,668 $321,000
Q2 2018 Aug 07, 2018	BUY	$145.72 - $169.96 $211,585 - $246,781	1,452 New	1,452 $247,000
Q1 2018 Apr 30, 2018	SELL	$151.6 - $177.13 $23,043 - $26,923	-152 Closed	0 $0
Q4 2017 Feb 08, 2018	SELL	$137.28 - $155.55 $4,118 - $4,666	-30 Reduced 16.48%	152 $23,000
Q3 2017 Nov 13, 2017	BUY	$148.13 - $162.24 $26,959 - $29,527	182	182 $28,000

Others Institutions Holding VRTX

# of Institutions

1,624

Shares Held

222M

Call Options Held

1.35M

Put Options Held

1.49M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $122B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenleaf Trust, based on Form 13F filings with the SEC.

News

Stay updated on Greenleaf Trust with notifications on news.

Account